Drugmaker Cipla Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drugmaker cipla ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drugmaker Cipla Ltd Today - Breaking & Trending Today

Market LIVE Updates: SGX Nifty indicates weak start; Asian markets mixed

Market LIVE Updates: Nifty Auto index rises while Nifty Metal seen under pressure. ....

Drugmaker Cipla Ltd , Stock Market , Stock Market Today , Arket Live , Stock Market , Hare Market , Hare Market Live , Ensex Share Price , Hare Market Today , Market Today , Hare Market News , Ifty Share Price , Se Nse Share Price , Ensex Share Market , Tock Market India , Tock Market Live , Stock Market Today , Indian Stock Market , Stock Market News , World Stock Market , Use Stock Market , Stock Market Sensex , Tock Market News Today ,

Cipla Q4 preview: Robust domestic traction, gRevlimid sales likely to give earnings a big boost

Cipla Q4 preview: The company is expected to double its consolidated net profit to Rs 723.4 crore from Rs 362.07 crore in the year-ago quarter. It is also seen as the biggest beneficiary of a strong flu season in India ....

Madhya Pradesh , Drugmaker Cipla Ltd , National Stock Exchange , Cipla Ltd , National Stock , Result Poll , 4 Earnings , 4 Results ,

Cipla to make and sell Eli Lilly's baricitinib to treat COVID-19

Updated:
Cipla’s deal with Lilly expands the its portfolio of COVID-19 drugs.
Share Article
AAA
Cipla’s deal with Lilly expands the its portfolio of COVID-19 drugs.
Drugmaker Cipla Ltd said on Monday it had entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly’s arthritis drug baricitinib for the treatment of COVID-19 patients.
The agreement comes at a time when India is struggling with a catastrophic second wave of the pandemic, leading to an acute shortage of coronavirus medicines such as remdesivir and tocilizumab.
Baricitinib has been given restricted emergency use approval by Central Drugs Standard Control Organisation (CDSCO) for use in combination with remdesivir for the treatment of hospitalised COVID-19 adult patients requiring supplemental oxygen, Cipla said in a filing to stock exchanges. ....

United States , Eli Lilly , Drugmaker Cipla Ltd , Drug Administration , Central Drugs Standard Control Organisation , ஒன்றுபட்டது மாநிலங்களில் , எலி லில்லி , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் ,